Targeting the chemokine ligand 2–chemokine receptor 2 axis provides the possibility of immunotherapy in chronic pain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the chemokine ligand 2–chemokine receptor 2 axis provides the possibility of immunotherapy in chronic pain

Published:2023-05 Issue: Volume:947 Page:175646
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Liu Shan,Lan Xiao-Bing,Tian Miao-Miao,Zhu Chun-Hao,Ma Lin,Yang Jia-Mei,Du Juan,Zheng Ping,Yu Jian-Qiang,Liu Ning

Funder

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

National Natural Science Foundation of China

Natural Science Foundation of Ningxia Province

Publisher

Elsevier BV

Subject

Pharmacology

Reference210 articles.

1. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. [Journal Article; Research Support, Non-U.S. Gov't];Abbadie;Proc. Natl. Acad. Sci. U. S. A.,2003

2. Effects of chronic pain on sleep quality and depression: a cross-sectional study. [Journal Article];Alhalal;Saudi Med. J.,2021

3. Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat;Alvarez;Pain,2014

4. Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder;Augé;Eur. J. Pharmacol.,2013

5. CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy;Aye-Mon;Mol. Pain,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic overlap and causality between COVID-19 and multi-site chronic pain: the importance of immunity;Frontiers in Immunology;2024-03-18

2. Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain;Molecules;2023-07-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3